In a recent study, we measured CSF biomarkers of neurodegeneration (NfL & pNfH) and inflammation (CHIT1, YKL-40, MCP-1) and correlated them to survival in ALS patients (34,911,782). This evidence concerns the gene CCL2 and amyotrophic lateral sclerosis.